IntroductionRisk factors for skin cancer (SC) in solid organ transplant recipients (SOTRs) include male gender, age over 50 years, white race, thoracic organ transplantation, duration of immunosuppression, and SC history prior to transplantation. Of these risk factors, white race is associated with the highest hazard ratio (9.04) for SC development. Though the prevalence of SC in white SOTRs is well‐documented, there is limited information regarding the prevalence of SC in darker skin phototypes. Pritchett et al. conducted the most recent assessment on rates of keratinocyte carcinoma (KC) in non‐white (i.e. Black, Asian, Hispanic and Pacific Islander) SOTRs. This study found that 5.1% of non‐white KTRs developed KC, of which 73% were cutaneous squamous cell carcinoma (cSCC). Chung et al. found that 41.6% of white SOTRs developed SC compared to 9.9% of non‐white (i.e. Asian, Hispanic, and Black) SOTRs. Although the prevalence of SC in white SOTRs and select non‐white SOTRs is documented, there is no information regarding SC prevalence in Native American SOTRs.In 2016, Native Americans received 233 solid organ transplantations, 147 of which were kidney transplants. These numbers are projected to increase because of the increasing prevalence of diabetes, hypertension, and end stage renal disease. It is estimated
International Journal of Dermatology – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera